Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trialḰazunori Toyoda, Naoko Kumagai, Kortaro Tanaka et al.|The Lancet Neurology|2019Cited by 216